PCPC / INCI Name Assignment
A standardized cosmetic ingredient identity assigned through the PCPC INCI nomenclature system, including Mono ID 40978.
Global Compliance & Quality
From engineered biomaterials to global ingredient identity
Standardized · Documented · TraceableA connected framework for ingredient identity, regulatory filing records, quality documentation and repeatable batch delivery.
Global Readiness Pathway
A traceable path from technology to commercial translation
Each step connects technical development with the records and quality controls required for clearer partner evaluation.
- 01
Technology Platform
- 02
Ingredient Identity
- 03
Regulatory Filing
- 04
Quality Documentation
- 05
Batch Traceability
- 06
Global Collaboration
Four Layers of Readiness
More than individual documents — a connected quality infrastructure
The value lies in how standardized identity, filing records, technical evidence and batch controls work together.
U.S. FDA Regulatory Filing
Product-specific filing records for AOWEISI AIR, SKIN and FEM, presented with their reference numbers and source documents.
Third-Party Testing & COA
Characterization, stability, safety and certificate-of-analysis documentation organized for technical review.
Batch Traceability & Quality System
Batch identity, production records and consistency controls support review from preparation through delivery.
Evidence Library
Review the source materials
Open the INCI assignment materials and the three product filing records. High-resolution versions load only when requested.
PCPC INCI Name Assignment
Assignment letter and revised AOWEISI application information for the standardized ingredient identity.
- Reference
- 2025-13746 · Mono ID 40978
- Date
- 2025-12-23
AOWEISI AIR Nasal Care Spray
U.S. FDA regulatory filing record supplied for the AOWEISI AIR product.
- Reference
- 53-696452-906587
- Date
- 2026-03-05
AOWEISI SKIN Freeze-Dried Essence
U.S. FDA regulatory filing record supplied for the AOWEISI SKIN product.
- Reference
- 53-540004-328983
- Date
- 2026-03-05
AOWEISI FEM Daily Care Essence
U.S. FDA regulatory filing record supplied for the AOWEISI FEM product.
- Reference
- 53-383315-598280
- Date
- 2026-03-05
Documented Quality System
Quality evidence built around repeatable delivery
Partners can review the records that connect material characterization, stability and batch identity to delivery readiness.
COA
Certificate-of-analysis records organized by material and batch.
Stability Data
Documented storage, protection and reconstitution considerations.
Safety Documentation
Safety-related material records available for technical review.
Batch Consistency
Controlled specifications support repeatable production outcomes.
Batch Traceability
Batch identity connects production records with delivered materials.
Characterization Records
Material identity and characterization data support partner evaluation.
Partnership Documentation
Build your next program on a clearer evidence base
Contact AOWEISI to discuss technical documentation, target-market needs and a suitable collaboration path.